AGARWALEYE Dr. Agarwal's Health Care Q4 FY26 results (Jan–Mar 2026) and concall
Dr. Agarwal's Healthcare Limited reported a strong Q4 and full year FY26, achieving record revenues over INR 2,000 crores and significant PAT growth. The company continued its aggressive greenfield expansion, adding 19 new facilities in Q4 and planning 60 more for FY27. While mature facilities showed robust same-store growth, new facilities incurred initial operating losses, and refractive surgery volumes saw some softness. The merger process is progressing, with an expected conclusion by Q3 FY27.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 23.8%, net profit down 59.3% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 255 | 268 | 281 | 302 | 309 +21% | 335 +25% | 348 +24% |
| EBITDA | 58 | 65 | 73 | 67 | 69 +19% | 80 +23% | 92 +26% |
| Net profit | -4 | 8 | 27 | 10 | 5 +225% | 14 +75% | 11 −59% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
